Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,279.14
+5.68 (0.45%)
At close: Oct 26, 2026, 4:00 PM EDT
1,276.49
-2.65 (-0.21%)
Pre-market: Oct 27, 2026, 7:35 AM EDT
Eli Lilly and Company Employees
Eli Lilly and Company had 50,000 employees as of December 31, 2025. The number of employees increased by 3,000 or 6.38% compared to the previous year. That makes Eli Lilly and Company the 717th largest employer in the world and 200th in the United States.
Employees
50,000
Change (1Y)
3,000
Growth (1Y)
6.38%
Revenue / Employee
$1,593,320
Profits / Employee
$534,220
Market Cap
1.14T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 50,000 | 3,000 | 6.38% |
| Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
| Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
| Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
| Dec 31, 2021 | 35,000 | 0 | - |
| Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
| Dec 31, 2019 | 33,625 | -5,055 | -13.07% |
| Dec 31, 2018 | 38,680 | -1,975 | -4.86% |
| Dec 31, 2017 | 40,655 | -1,320 | -3.14% |
| Dec 31, 2016 | 41,975 | 700 | 1.70% |
| Dec 31, 2015 | 41,275 | 2,140 | 5.47% |
| Dec 31, 2014 | 39,135 | 1,210 | 3.19% |
| Dec 31, 2013 | 37,925 | -425 | -1.11% |
| Dec 31, 2012 | 38,350 | 270 | 0.71% |
| Dec 31, 2011 | 38,080 | -270 | -0.70% |
| Dec 31, 2010 | 38,350 | -2,010 | -4.98% |
| Dec 31, 2009 | 40,360 | -140 | -0.35% |
| Dec 31, 2008 | 40,500 | -100 | -0.25% |
| Dec 31, 2007 | 40,600 | -900 | -2.17% |
| Dec 31, 2006 | 41,500 | -1,100 | -2.58% |
| Dec 31, 2005 | 42,600 | -1,900 | -4.27% |
| Dec 31, 2004 | 44,500 | -1,600 | -3.47% |
| Dec 31, 2003 | 46,100 | 2,400 | 5.49% |
| Dec 31, 2002 | 43,700 | 2,600 | 6.33% |
| Dec 31, 2001 | 41,100 | 5,400 | 15.13% |
| Dec 31, 2000 | 35,700 | 4,400 | 14.06% |
| Dec 31, 1999 | 31,300 | 1,500 | 5.03% |
| Dec 31, 1998 | 29,800 | -1,300 | -4.18% |
| Dec 31, 1997 | 31,100 | 1,900 | 6.51% |
| Dec 31, 1996 | 29,200 | 2,400 | 8.96% |
| Dec 31, 1995 | 26,800 | 1,900 | 7.63% |
| Dec 31, 1994 | 24,900 | -7,800 | -23.85% |
| Dec 31, 1993 | 32,700 | 500 | 1.55% |
| Dec 31, 1992 | 32,200 | 1,400 | 4.55% |
| Dec 31, 1991 | 30,800 | 1,300 | 4.41% |
| Dec 31, 1990 | 29,500 | 1,700 | 6.12% |
| Dec 31, 1989 | 27,800 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| Pfizer | 75,000 |
| Novo Nordisk | 69,505 |
| GSK plc | 66,841 |
| AbbVie | 57,000 |
LLY News
- 15 hours ago - US judge refuses to block Eli Lilly weight-loss drug ads, rules against Novo Nordisk - Reuters
- 16 hours ago - Wall Street Has High Expectations for Eli Lilly Stock (LLY) Heading into Earnings - TipRanks
- 20 hours ago - Lilly declares fourth-quarter 2026 dividend - PRNewsWire
- 1 day ago - Eli Lilly price target raised to $1,450 from $1,385 at Bernstein - TheFly
- 1 day ago - Eli Lilly announces new first-line data on olomorasib at 2026 ESMO - TheFly
- 1 day ago - Eli Lilly announces new Phase 1 data on Sofe-M - TheFly
- 2 days ago - New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer - PRNewsWire
- 3 days ago - Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026 - PRNewsWire